Patent holdings for IPC class A61K 31/4741

Total number of patents in this class: 493

10-year publication summary

48
21
30
39
33
45
25
42
36
11
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
The United States of America, as represented by the Secretary, Department of Health and Human Services
2837
17
H4 Orphan Pharma
10
10
The Regents of the University of California
19803
9
Purdue Research Foundation
3561
8
Florida State University Research Foundation, Inc.
734
8
Gilead Sciences, Inc.
2026
8
Eli Lilly and Company
3809
7
Shanghai Hengrui Pharmaceutical Co., Ltd.
629
7
vTv Therapeutics LLC
152
7
The Trustees of the University of Pennsylvania
4304
6
CBA Pharma, Inc.
14
6
Jiangsu Hengrui Medicine Co., Ltd.
706
6
Trustees of Boston University
973
6
H. Lundbeck A/S
1205
6
Algernon Pharmaceuticals Inc.
23
6
Boehringer Ingelheim International GmbH
4701
5
Arbutus Biopharma Corporation
177
5
Emory University
1618
5
BASF SE
20758
4
Mitotech SA
30
4
Other owners 353